Accelerated Kidney Function Decline Seen With COVID-19 Versus Pneumonia
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- COVID-19 is associated with accelerated decline in kidney function, especially after hospitalization, according to a study published online Dec. 26 in JAMA Network Open.
Viyaasan Mahalingasivam, from the London School of Hygiene and Tropical Medicine, and colleagues examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections in a cohort study using linked data from the Stockholm Creatinine Measurements Project between Feb. 1, 2018, and Jan. 1, 2022. Data were included for all hospitalized and nonhospitalized adults in the database with at least one estimated glomerular filtration rate (eGFR) measurement in the two years prior to a COVID-19 positive test result (134,565 individuals) or pneumonia diagnosis (35,987 individuals).
The median baseline eGFR was 94 and 79 mL/min/1.73 m2 for the COVID-19 and pneumonia cohorts, respectively. The researchers found that both infections demonstrated accelerated annual eGFR decline after adjustment for covariates, with a greater magnitude of decline seen after COVID-19 than pneumonia (3.4 and 2.3 percent, respectively). Among individuals hospitalized for COVID-19, the decline was more severe (5.4 percent) but was similar among those hospitalized for pneumonia.
"We therefore propose that people who were hospitalized for COVID-19 receive closer monitoring of kidney function to ensure prompt diagnosis and optimized management of chronic kidney disease to effectively prevent complications and further decline," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Further Support and Information on COVID-19
Read this next
Increase in Chronic Digestive Disorders Seen During Pandemic
WEDNESDAY, July 9, 2025 -- There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a...
Exposure to Trihalomethanes Linked to Chronic Kidney Disease
TUESDAY, July 8, 2025 -- Exposure to trihalomethanes, especially brominated trihalomethanes, in residential community water supplies (CWS) is associated with an increased risk for...
COVID-19 Pandemic Yielded Indirect Increases in Disease Burden
MONDAY, July 7, 2025 -- The COVID-19 pandemic yielded indirect increases in disease burden for specific causes, including mental health disorders, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.